Previous 10 | Next 10 |
CAMBRIDGE, Mass., Aug. 30, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced that Chip Clark, president and chief executive officer, will present at two leading healthcare confer...
Genocea Biosciences, Inc. (GNCA) Q2 2019 Earnings Conference Call July 25, 2019, 08:30 ET Company Participants Daniel Ferry - LifeSci Advisors William Clark - President, CEO & Director Diantha Duvall - CFO Thomas Davis - Chief Medical Officer Conference Call Participants...
Genocea Biosciences (NASDAQ: GNCA ): Q2 GAAP EPS of -$0.42 beats by $0.24 . More news on: Genocea Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Initiated Part B of Phase 1/2a clinical trial of neoantigen vaccine candidate GEN-009; Plans to present additional GEN-009 immunogenicity data at ESMO 2019 Conference call today at 8:30 am ET CAMBRIDGE, Mass., July 25, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc . (...
CAMBRIDGE, Mass., July 18, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, will host its second-quarter 2019 financial results and corporate update conference call and live audio webcast on Th...
Oasmia Pharmaceutical AB (NASDAQ: OASM ) +22% . More news on: Oasmia Pharmaceutical AB (publ), Sangamo Therapeutics, Inc., Aytu BioScience, Inc., Stocks on the move, Read more ...
InsiderInsights' Daily Round-Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi...
InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi...
Scholar Rock Holding (NASDAQ: SRRK ) -11% on pricing share offering. More news on: Scholar Rock Holding Corporation, Carnival plc, Carnival Corporation, Stocks on the move, Read more ...
Genocea Biosciences (NASDAQ: GNCA ) has priced its public offering of 10.5M common shares at $3.50/share, for gross proceeds of $36.75M. More news on: Genocea Biosciences, Inc., Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Genocea Biosciences Inc. Company Name:
GNCA Stock Symbol:
NASDAQ Market:
Genocea Biosciences Inc. Website: